Behaviour and Quantitation of Extrinsic (Tissue-Type) Plasminogen Activator in Human Blood

Summary Functional assay of extrinsic (tissue-type) plasminogen activator (EPA) in plasma on fibrin plates was evaluated. Using specific quenching antibodies, we demonstrated the method to be specific for EPA under all conditions tested. Contributions of urokinases and intrinsic activators were excluded. The quantity of EPA in blood samples, as compared with purified uterine tissue activator, shows 1 blood activator unit (BAU) to be comparable to 0.93 ng. The median values for EPA activity for healthy volunteers were: baseline, 1.9 BAU/ml (n = 123); diurnal, 5.5 BAU/ml (n = 12); DDAVP administration, 11.7 BAU/ml (n = 39); exhaustive exercise, 25 BAU/ml (n = 24); venous occlusion (15 min), 35 BAU/ml (n = 61). A large inter-individual variation in EPA activity was found, while individual baseline values tended to be constant for periods of weeks. In vitro in blood EPA activity shows a disappearance of 50% in about 90 min at 37° C; EPA activity in euglobulin fractions is stable for ≤2 hr at 37° C. A rapid decrease in EPA activity occurs in vivo, as noted after extracorporal circulation and exercise stimulation (t½ decay, 2-5 min).

[1]  C. Kluft,et al.  DEMONSTRATION OF UROKINASE‐RELATED FIBRINOLYTIC ACTIVITY IN HUMAN PLASMA , 1982, British journal of haematology.

[2]  W. Schleuning,et al.  Isolation and characterization of urokinase from human plasma. , 1982, The Journal of biological chemistry.

[3]  C. Korninger,et al.  Turnover of Human Extrinsic (Tissue-Type) Plasminogen Activator in Rabbits , 1981, Thrombosis and Haemostasis.

[4]  C. Korninger,et al.  Neutralization of Human Extrinsic (Tissue-Type) Plasminogen Activator in Human Plasma: No Evidence for a Specific Inhibitor , 1981, Thrombosis and Haemostasis.

[5]  D. Collen,et al.  Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. , 1981, The Journal of biological chemistry.

[6]  D. Rijken,et al.  Relationship between tissue plasminogen activator and the activators in blood and vascular wall. , 1980, Thrombosis research.

[7]  D. Rijken,et al.  Purification and partial characterization of plasminogen activator from human uterine tissue. , 1979, Biochimica et biophysica acta.

[8]  C. Kluft,et al.  Factor XII-Dependent Fibrinolysis: A Double Function of Plasma Kallikrein and the Occurrence of a Previously Undescribed Factor XII- and Kallikrein-Dependent Plasminogen Proactivator , 1979, Thrombosis and Haemostasis.

[9]  C. Kluft Studies on the Fibrinolytic System in Human Plasma: Quantitative Determination of Plasminogen Activators and Proactivators , 1979, Thrombosis and Haemostasis.

[10]  B. Binder,et al.  Purification and characterization of human vascular plasminogen activator derived from blood vessel perfusates. , 1979, The Journal of biological chemistry.

[11]  K. V. von Kaulla,et al.  Rapid increase of fibrinolytic activity in pig and rat after exclusion of the liver from the circulation and its control by various organs. , 1979, Acta hepato-gastroenterologica.

[12]  T. Heinze,et al.  Isolation of plasminogen activator from human plasma by chromatography on lysine-sepharose. , 1978, Archives of biochemistry and biophysics.

[13]  W. Nieuwenhuizen,et al.  Flourogenic peptide amide substrates for the estimation of plasminogen activators and plasmin. , 1977, Analytical biochemistry.

[14]  F. Haverkate,et al.  Dose-response Curves in the Fibrin Plate Assay Fibrinolytic Activity of Proteases , 1974, Thrombosis and Haemostasis.

[15]  H. Brummelhuis,et al.  Contributions to the Optimal Use of Human Blood , 1974, Vox sanguinis.

[16]  A. Gader,et al.  A new vasopressin analogue and fibrinolysis. , 1973, Lancet.

[17]  I. Nilsson,et al.  “FIBRINOLYTIC CAPACITY” IN HEALTHY VOLUNTEERS AT DIFFERENT AGES AS STUDIED BY STANDARDIZED VENOUS OCCLUSION OF ARMS AND LEGS , 1972, Acta medica Scandinavica.

[18]  D. Redwood,et al.  Blood Fibrinolytic Activity in Man: Diurnal Variation and the Response to Varying Intensities of Exercise , 1970, Circulation research.

[19]  A. Fletcher,et al.  ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES. , 1964, The Journal of clinical investigation.

[20]  C. Kluft,et al.  The Factor XII-Independent Plasminogen Proactivator System Of Plasma Includes Urokinase-Related Activity , 1981, Thrombosis and Haemostasis.

[21]  C. Kluft,et al.  An Enhancing Effect Of Smoking On Fibrinolysis , 1981, Thrombosis and Haemostasis.

[22]  C. Kluft,et al.  Urokinase-Related Fibrinolytic Activity In Human Plasma , 1981, Thrombosis and Haemostasis.

[23]  C. Kluft Occurrence of C1 inactivator and other proteinase inhibitors in euglobulin fractions and their influence on fibrinolytic activity. , 1976, Haemostasis.

[24]  E. Deutsch Fibrinolysis. A Standardized Fibrin Plate Method and a Fibrinolytic Assay of Plasminogen , 1968, Thrombosis and Haemostasis.